Patents by Inventor Petra Meissner

Petra Meissner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9428727
    Abstract: The present application describes an optimized medium for growth of mammalian cells as well as polypeptide production. The cell culture medium is characterized by a Sow ratio of sodium to potassium ions, it further relates to the method of producing polypeptides using such cell culture media. Sn another aspect, the method of polypeptide production can also comprise a temperature shift and/or a pH-shift to further optimize growth and product yield.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: August 30, 2016
    Assignee: Novartis AG
    Inventors: Christian Leist, Petra Meissner, Jörg Schmidt
  • Publication number: 20130122543
    Abstract: The present application describes an optimized medium for growth of mammalian cells as well as polypeptide production. The cell culture medium is characterized by a Sow ratio of sodium to potassium ions, it further relates to the method of producing polypeptides using such cell culture media. Sn another aspect, the method of polypeptide production can also comprise a temperature shift and/or a pH-shift to further optimize growth and product yield.
    Type: Application
    Filed: April 25, 2011
    Publication date: May 16, 2013
    Applicant: Novartis AG
    Inventors: Christian Leist, Petra Meissner, Jörg Schmidt
  • Patent number: 6251672
    Abstract: Mammalian cells which require contact with cell surface proteins for activation, differentiation and/or proliferation are cultured in contact with an immobilized mammalian cell, with an immobilized membrane vesicle from a mammalian cell or with immobilized membrane vesicles from at least two mammalian cell populations. The mammalian cell or membrane vesicle can be modified with a first partner of a biological binding pair, and immobilized on a solid carrier via a second partner of the biological binding pair. Culturing can be with a first immobilized membrane vesicle and subsequently with a second immobilized membrane vesicle. The membrane vesicle contains part of the natural surface of a mammalian cell that includes a signal triggering surface protein. The membrane vesicle can be immobilized via a binding partner of a cell surface molecule.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: June 26, 2001
    Assignee: GSF-Forschungszentrum fur Umwelt und Gesundheit
    Inventors: Manfred Kubbies, Peter Dörmer, Petra Meissner
  • Patent number: 5152437
    Abstract: In a device for connecting apparatus for withdrawing ultrapure liquids from containers, the connection plate 4 is provided with three bores 5, 6, 7, of which two bores 5, 6 each extend through a socket 8 for vertical pipes. The top plate 9 has an integrated valve body 23 for accommodating at least two valve heads 2, 3 and three bores 10, 11, 12, which are congruent with the bores 5, 6, 7 of the connection plate 4. The bore 12 extends through the valve body 23, and the two other bores 10, 11 terminate, at one end thereof, in pipe sockets 29, 30, which project into the bores 5, 6 of the connection plate 4, and, at the other end thereof, in channels 31, 32, 33, 34 for the ultrapure liquids, which are arranged in the valve body 23 and are interrupted by the valve heads 2, 3.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: October 6, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Heinz-Dieter Klein, Petra Meissner, Norbert Ochs, Martin Schottler, Wolfgang Sievert
  • Patent number: RE48864
    Abstract: The present application describes an optimized medium for growth of mammalian cells as well as polypeptide production. The cell culture medium is characterized by a Sow ratio of sodium to potassium ions, it further relates to the method of producing polypeptides using such cell culture media. Sn another aspect, the method of polypeptide production can also comprise a temperature shift and/or a pH-shift to further optimize growth and product yield.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: December 28, 2021
    Assignee: Novartis AG
    Inventors: Christian Leist, Petra Meissner, Jörg Schmidt